Physician profile
Natalya Tkachenko
NPI 1740491927
$804.05
in general payments reported to CMS, 2019-2025
12 companies · $729 in 2025
The $729 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $75.46 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $149.99 | 2025 | Lumryz |
| Incyte Corporation | $124.25 | 2025 | Opzelura |
| Shield Therapeutics INC | $107.51 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $75.62 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $61.18 | 2024-2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.81 | 2025 | Jardiance |
| Paratek Pharmaceuticals, INC. | $60.43 | 2025 | Nuzyra |
| Exact Sciences Corporation | $58.45 | 2025 | Cologuard Collection Kit |
| Tandem Diabetes Care, INC. | $29.88 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sun Pharmaceutical Industries INC. | $28.94 | 2025 | |
| Abbvie INC. | $25.17 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $21.82 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalya Tkachenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.